These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

75 related items for PubMed ID: 2466046

  • 1. Plasma neuropeptide Y concentrations in patients with neuroendocrine tumors.
    Grouzmann E, Comoy E, Bohuon C.
    J Clin Endocrinol Metab; 1989 Apr; 68(4):808-13. PubMed ID: 2466046
    [Abstract] [Full Text] [Related]

  • 2. Production and characterization of four anti-neuropeptide Y monoclonal antibodies.
    Grouzmann E, Comoy E, Walker P, Burnier M, Bohuon C, Waeber B, Brunner H.
    Hybridoma; 1992 Aug; 11(4):409-24. PubMed ID: 1383123
    [Abstract] [Full Text] [Related]

  • 3. Neuropeptide Y as a plasma marker for phaeochromocytoma, ganglioneuroblastoma and neuroblastoma.
    Mouri T, Sone M, Takahashi K, Itoi K, Totsune K, Hayashi Y, Hasegawa S, Ohneda M, Murakami O, Miura Y.
    Clin Sci (Lond); 1992 Aug; 83(2):205-11. PubMed ID: 1327637
    [Abstract] [Full Text] [Related]

  • 4. Expression and precursor processing of neuropeptide Y in human pheochromocytoma and neuroblastoma tumors.
    O'Hare MM, Schwartz TW.
    Cancer Res; 1989 Dec 15; 49(24 Pt 1):7010-4. PubMed ID: 2582442
    [Abstract] [Full Text] [Related]

  • 5. Neuropeptide Y and its flanking peptide in human endocrine tumors and plasma.
    Allen JM, Yeats JC, Causon R, Brown MJ, Bloom SR.
    J Clin Endocrinol Metab; 1987 Jun 15; 64(6):1199-204. PubMed ID: 3571423
    [Abstract] [Full Text] [Related]

  • 6. Plasma neuropeptide Y of children with neuroblastoma in relation to stage, age and prognosis, and tissue neuropeptide Y.
    Dötsch J, Christiansen H, Hänze J, Lampert F, Rascher W.
    Regul Pept; 1998 Sep 25; 75-76():185-90. PubMed ID: 9802408
    [Abstract] [Full Text] [Related]

  • 7. Neuropeptide Y and neuron-specific enolase levels in benign and malignant pheochromocytomas.
    Grouzmann E, Gicquel C, Plouin PF, Schlumberger M, Comoy E, Bohuon C.
    Cancer; 1990 Oct 15; 66(8):1833-5. PubMed ID: 2208039
    [Abstract] [Full Text] [Related]

  • 8. Elevated plasma concentrations of neuropeptide Y in children and adults with chronic and terminal renal failure.
    Bald M, Gerigk M, Rascher W.
    Am J Kidney Dis; 1997 Jul 15; 30(1):23-7. PubMed ID: 9214397
    [Abstract] [Full Text] [Related]

  • 9. Significance of plasma neuropeptide Y (NPY) in diagnosis and prognosis of neuroblastoma.
    Hayashi Y, Ohi R, Sone M, Takahashi K, Mouri T, Watanabe T, Yaoita S, Nakamura M.
    Prog Clin Biol Res; 1991 Jul 15; 366():359-65. PubMed ID: 2068151
    [No Abstract] [Full Text] [Related]

  • 10. Neuropeptide Y in neuroblastoma: increased concentration in metastasis, release during surgery, and characterization of plasma and tumor extracts.
    Kogner P, Björk O, Theodorsson E.
    Med Pediatr Oncol; 1993 Jul 15; 21(5):317-22. PubMed ID: 8492745
    [Abstract] [Full Text] [Related]

  • 11. [Bilateral adrenal pheochromocytoma. Diagnosis and follow-up using the clonidine test and measurement of plasma neuropeptide Y concentration].
    Eisenhut S, Rascher W, Lang RE.
    Monatsschr Kinderheilkd; 1990 Sep 15; 138(9):631-4. PubMed ID: 2233767
    [Abstract] [Full Text] [Related]

  • 12. Production of immunoreactive corticotropin-releasing hormone in various neuroendocrine tumors.
    Tsuchihashi T, Yamaguchi K, Abe K, Yanaihara N, Saito S.
    Jpn J Clin Oncol; 1992 Aug 15; 22(4):232-7. PubMed ID: 1359172
    [Abstract] [Full Text] [Related]

  • 13. Lower plasma neuropeptide Y level in patients with atypical febrile convulsions.
    Lin LC, Lee WT, Chen IJ, Yang RC.
    Kaohsiung J Med Sci; 2010 Jan 15; 26(1):8-12. PubMed ID: 20040467
    [Abstract] [Full Text] [Related]

  • 14. Production, characterization, and expression of neuropeptide Y by human pheochromocytoma.
    deS Senanayake P, Denker J, Bravo EL, Graham RM.
    J Clin Invest; 1995 Nov 15; 96(5):2503-9. PubMed ID: 7593641
    [Abstract] [Full Text] [Related]

  • 15. Serial measurements of neuropeptide Y in plasma for monitoring neuroblastoma in children.
    Rascher W, Kremens B, Wagner S, Feth F, Hunneman DH, Lang RE.
    J Pediatr; 1993 Jun 15; 122(6):914-6. PubMed ID: 8501569
    [Abstract] [Full Text] [Related]

  • 16. Alterations in plasma neuropeptide Y immunoreactivity and catecholamine levels during surgical removal of pheochromocytoma.
    Januszewicz W, Wocial B, Ignatowska-Switalska H, Dutkiewicz-Raczkowska M, Feltynowski T, Januszewicz A, Tapiński M, Zukowska-Grójec Z, Szostek M.
    J Hypertens; 1998 Apr 15; 16(4):543-7. PubMed ID: 9797201
    [Abstract] [Full Text] [Related]

  • 17. Plasma neuropeptide Y (NPY): a novel marker of neuroblastoma.
    Kogner P, Theodorsson E, Björk O.
    Prog Clin Biol Res; 1991 Apr 15; 366():367-73. PubMed ID: 2068152
    [No Abstract] [Full Text] [Related]

  • 18. Comparative structural requirements of brain neuropeptide Y binding sites and vas deferens neuropeptide Y receptors.
    Martel JC, Fournier A, St-Pierre S, Dumont Y, Forest M, Quirion R.
    Mol Pharmacol; 1990 Oct 15; 38(4):494-502. PubMed ID: 2172766
    [Abstract] [Full Text] [Related]

  • 19. Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones.
    Nobels FR, Kwekkeboom DJ, Coopmans W, Schoenmakers CH, Lindemans J, De Herder WW, Krenning EP, Bouillon R, Lamberts SW.
    J Clin Endocrinol Metab; 1997 Aug 15; 82(8):2622-8. PubMed ID: 9253344
    [Abstract] [Full Text] [Related]

  • 20. Release of neuropeptide Y from pheochromocytomas.
    Takahashi K, Mouri T, Sone M, Murakami O, Itoi K, Ohneda M, Yoshinaga K.
    Endocrinol Jpn; 1990 Feb 15; 37(1):53-60. PubMed ID: 2384052
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.